We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+3.43%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$10.5B
AUM Growth
+$2.57B
(+32%)
Cap. Flow
+$2.52B
Cap. Flow
% of AUM
23.97%
Top 10 Holdings %
Top 10 Hldgs %
3.28%
Holding
3,782
New
851
Increased
1,449
Reduced
1,127
Closed
344
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$38.7M |
| 2 |
Amazon
AMZN
|
+$33.2M |
| 3 |
International Paper
IP
|
+$32.8M |
| 4 |
XYZ
Block Inc
XYZ
|
+$32.6M |
| 5 |
Capital One
COF
|
+$30.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$28M |
| 2 |
Dick's Sporting Goods
DKS
|
+$27.9M |
| 3 |
Eli Lilly
LLY
|
+$24.9M |
| 4 |
Vail Resorts
MTN
|
+$24.7M |
| 5 |
Accenture
ACN
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.79% |
| 2 | Financials | 13.65% |
| 3 | Industrials | 12.55% |
| 4 | Consumer Discretionary | 12.48% |
| 5 | Healthcare | 12.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICAD
3226
DELISTED
iCAD Inc
ICAD
| $88K | ﹤0.01% |
+12,245
| New | +$109K |
|
3227
Morningstar
MORN
$7.53B
| $88K | ﹤0.01% |
256
-3,575
| -93% | -$1.11M |
|
|
DBD
3228
DELISTED
Diebold Nixdorf Incorporated
DBD
| $88K | ﹤0.01% |
9,744
-1,202
| -11% | -$11.2K |
|
3229
Cabaletta Bio
CABA
$455M
| $87K | ﹤0.01% |
22,880
+12,106
| +112% | +$129K |
|
3230
Redwire
RDW
$3.25B
| $87K | ﹤0.01% |
12,931
-5,284
| -29% | -$50.9K |
|
|
SOS
3231
SOS Limited
SOS
$14.6M
| $86K | ﹤0.01% |
+140
| New | +$171K |
|
3232
Archrock
AROC
$5.8B
| $84K | ﹤0.01% |
+11,181
| New | +$89.9K |
|
3233
Concrete Pumping Holdings
BBCP
$491M
| $84K | ﹤0.01% |
10,304
+744
| +8% | +$6.36K |
|
|
NPKI
3234
NPK International
NPKI
$1.14B
| $84K | ﹤0.01% |
+28,665
| New | +$92K |
|
3235
Assembly Biosciences
ASMB
$529M
| $83K | ﹤0.01% |
2,971
+1,400
| +89% | +$45.9K |
|
|
SYRS
3236
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $83K | ﹤0.01% |
2,532
-6,167
| -71% | -$250K |
|
|
CBAY
3237
DELISTED
Cymabay Therapeutics
CBAY
| $83K | ﹤0.01% |
24,491
+5,778
| +31% | +$21.9K |
|
|
SPPI
3238
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $83K | ﹤0.01% |
+65,504
| New | +$117K |
|
|
SCPX
3239
DELISTED
Scorpius Holdings, Inc.
SCPX
| $82K | ﹤0.01% |
+7
| New | +$134K |
|
|
SONX
3240
DELISTED
Sonendo, Inc.
SONX
| $82K | ﹤0.01% |
+14,241
| New | +$128K |
|
|
OBSV
3241
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $82K | ﹤0.01% |
41,201
+30,094
| +271% | +$72.8K |
|
3242
VEON
VEON
$3.95B
| $81K | ﹤0.01% |
1,892
-548
| -22% | -$26.7K |
|
3243
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
| $80K | ﹤0.01% |
+13,558
| New | +$85.2K |
|
3244
Revvity
RVTY
$12.8B
| $80K | ﹤0.01% |
400
-20,426
| -98% | -$3.69M |
|
3245
SelectQuote
SLQT
$121M
| $79K | ﹤0.01% |
8,688
-28,018
| -76% | -$307K |
|
3246
Aaon
AAON
$7.77B
| $78K | ﹤0.01% |
1,476
-24,564
| -94% | -$1.23M |
|
3247
Acumen Pharmaceuticals
ABOS
$176M
| $78K | ﹤0.01% |
+11,545
| New | +$127K |
|
|
HDSN
3248
Hudson Technologies
HDSN
$235M
| $78K | ﹤0.01% |
17,496
+5,844
| +50% | +$22.7K |
|
3249
TAL Education Group
TAL
$6.87B
| $78K | ﹤0.01% |
19,785
-23,738
| -55% | -$107K |
|
|
ONCR
3250
DELISTED
Oncorus, Inc.
ONCR
| $78K | ﹤0.01% |
+14,887
| New | +$115K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q4 2021 Portfolio in Review
As of Q4 2021, Cubist Systematic Strategies held 3,782 positions worth $10.5B, up 32% from $7.94B the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.
Cubist Systematic Strategies deployed $2.52B of net new capital in Q4 2021, opening 851 new positions and adding to 1,449 existing holdings. Its largest new stake was Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant: 2,028,600 shares worth $20.6M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Estee Lauder, an estimated $28M trimmed.
- Cubist Systematic Strategies's largest Q4 2021 buy was Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant: 2,028,600 shares worth $20.6M.
- Cubist Systematic Strategies added most to Medtronic in Q4 2021, an estimated $38.7M increase.
- Cubist Systematic Strategies's biggest Q4 2021 reduction was Estee Lauder, cutting an estimated $28M.
- Cubist Systematic Strategies fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $5.95M.
- Cubist Systematic Strategies's ten largest holdings make up 3.3% of its $10.5B portfolio in Q4 2021.
- Cubist Systematic Strategies opened 851 new positions and closed 344 in Q4 2021.
- Cubist Systematic Strategies's portfolio value rose 32% quarter-over-quarter to $10.5B.
Based on Cubist Systematic Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.